Liquid biopsy of oesophageal squamous cell carcinoma: implications in diagnosis, prognosis, and treatment monitoring

References

• Sung H, Ferlay J, Siegel RL, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71(3):209–249. doi: 10.3322/caac.21660.
   PubMed Web of Science ®Google Scholar
• Xia C, Dong X, Li H, et al. Cancer statistics in China and United States, 2022: profiles, trends, and determinants. Chin Med J. 2022;135(5):584–590. doi: 10.1097/CM9.0000000000002108.
   PubMed Web of Science ®Google Scholar
• Morgan E, Soerjomataram I, Rumgay H, et al. The global landscape of esophageal squamous cell carcinoma and esophageal adenocarcinoma incidence and mortality in 2020 and projections to 2040: new estimates from GLOBOCAN 2020. Gastroenterology. 2022;163(3):649–658.e2. doi: 10.1053/j.gastro.2022.05.054.
   PubMed Web of Science ®Google Scholar
• Lin L, Li Z, Yan L, et al. Global, regional, and national cancer incidence and death for 29 cancer groups in 2019 and trends analysis of the global cancer burden, 1990–2019. J Hematol Oncol. 2021;14(1):197. doi: 10.1186/s13045-021-01213-z.
   PubMed Web of Science ®Google Scholar
• Shi Y, Ge X, Ju M, et al. Circulating tumor cells in esophageal squamous cell carcinoma – mini review. Cancer Manag Res. 2021;13:8355–8365. doi: 10.2147/CMAR.S337489.
   PubMedGoogle Scholar
• Wang Y, Huang Y, Chase RC, et al. Global burden of digestive diseases: a systematic analysis of the global burden of diseases study, 1990 to 2019. Gastroenterology. 2023;165(3):773–783.e15. doi: 10.1053/j.gastro.2023.05.050.
   PubMed Web of Science ®Google Scholar
• Cotton S, Ferreira D, Soares J, et al. Target score—a proteomics data selection tool applied to esophageal cancer identifies GLUT1-Sialyl Tn glycoforms as biomarkers of cancer aggressiveness. Int J Mol Sci. 2021;22(4):1664. doi: 10.3390/ijms22041664.
   PubMed Web of Science ®Google Scholar
• Visaggi P, Barberio B, Ghisa M, et al. Modern diagnosis of early esophageal cancer: from blood biomarkers to advanced endoscopy and artificial intelligence. Cancers. 2021;13(13):3162. doi: 10.3390/cancers13133162.
   PubMed Web of Science ®Google Scholar
• Lan W, Lihong L, Chun H, et al. Comparison of efficacy and safety between simultaneous integrated boost intensity-modulated radiotherapy and standard-dose intensity-modulated radiotherapy in locally advanced esophageal squamous cell carcinoma: a retrospective study. Strahlenther Onkol. 2022;198(9):802–811. doi: 10.1007/s00066-021-01894-y.
   PubMed Web of Science ®Google Scholar
• Chen R, Liu Y, Song G, et al. Effectiveness of one-time endoscopic screening programme in prevention of upper gastrointestinal cancer in China: a multicentre population-based cohort study. Gut. 2021;70(2):251–260. doi: 10.1136/gutjnl-2019-320200.
   PubMed Web of Science ®Google Scholar
• Codipilly DC, Qin Y, Dawsey SM, et al. Screening for esophageal squamous cell carcinoma: recent advances. Gastrointest Endosc. 2018;88(3):413–426. doi: 10.1016/j.gie.2018.04.2352.
   PubMed Web of Science ®Google Scholar
• Tong YS, Wang XW, Zhou XL, et al. Identification of the long non-coding RNA POU3F3 in plasma as a novel biomarker for diagnosis of esophageal squamous cell carcinoma. Mol Cancer. 2015;14(1):3. doi: 10.1186/1476-4598-14-3.
   PubMed Web of Science ®Google Scholar
• Ren C, He P, Zhang J, et al. Malignant characteristics of circulating tumor cells and corresponding primary tumor in a patient with esophageal squamous cell carcinoma before and after surgery. Cancer Biol Ther. 2011;11(7):633–638. doi: 10.4161/cbt.11.7.14950.
   PubMed Web of Science ®Google Scholar
• Diaz LA, Bardelli A. Liquid biopsies: genotyping circulating tumor DNA. J Clin Oncol. 2014;32(6):579–586. doi: 10.1200/JCO.2012.45.2011.
   PubMed Web of Science ®Google Scholar
• Siravegna G, Marsoni S, Siena S, et al. Integrating liquid biopsies into the management of cancer. Nat Rev Clin Oncol. 2017;14(9):531–548. doi: 10.1038/nrclinonc.2017.14.
   PubMed Web of Science ®Google Scholar
• Nikanjam M, Kato S, Kurzrock R. Liquid biopsy: current technology and clinical applications. J Hematol Oncol. 2022;15(1):131. doi: 10.1186/s13045-022-01351-y.
   PubMed Web of Science ®Google Scholar
• Yu D, Li Y, Wang M, et al. Exosomes as a new frontier of cancer liquid biopsy. Mol Cancer. 2022;21(1):56. doi: 10.1186/s12943-022-01509-9.
   PubMed Web of Science ®Google Scholar
• Li K, Lin Y, Luo Y, et al. A signature of saliva-derived exosomal small RNAs as predicting biomarker for esophageal carcinoma: a multicenter prospective study. Mol Cancer. 2022;21(1):21. doi: 10.1186/s12943-022-01499-8.
   PubMed Web of Science ®Google Scholar
• Espejo C, Lyons B, Woods GM, et al. Early cancer biomarker discovery using DIA-MS proteomic analysis of EVs from peripheral blood. Methods Mol Biol. 2023;2628:127–152. doi: 10.1007/978-1-0716-2978-9_9.
   PubMedGoogle Scholar
• Tivey A, Church M, Rothwell D, et al. Circulating tumour DNA—looking beyond the blood. Nat Rev Clin Oncol. 2022;19(9):600–612. doi: 10.1038/s41571-022-00660-y.
   PubMed Web of Science ®Google Scholar
• Yang D, Zhang W, Zhang H, et al. Progress, opportunity, and perspective on exosome isolation – efforts for efficient exosome-based theranostics. Theranostics. 2020;10(8):3684–3707. doi: 10.7150/thno.41580.
   PubMed Web of Science ®Google Scholar
• Li X, Li C, Zhang L, et al. The significance of exosomes in the development and treatment of hepatocellular carcinoma. Mol Cancer. 2020;19(1):1. doi: 10.1186/s12943-019-1085-0.
   PubMed Web of Science ®Google Scholar
• Janockova J, Matejova J, Moravek M, et al. Small extracellular vesicles derived from human chorionic MSCs as modern perspective towards cell-free therapy. Int J Mol Sci. 2021;22(24):13581. doi: 10.3390/ijms222413581.
   PubMed Web of Science ®Google Scholar
• Sufianov A, Kostin A, Begliarzade S, et al. Exosomal non coding RNAs as a novel target for diabetes mellitus and its complications. Noncoding RNA Res. 2023;8(2):192–204. doi: 10.1016/j.ncrna.2023.02.001.
   PubMed Web of Science ®Google Scholar
• Lin Y, Dong H, Deng W, et al. Evaluation of salivary exosomal chimeric GOLM1-NAA35 RNA as a potential biomarker in esophageal carcinoma. Clin Cancer Res. 2019;25(10):3035–3045. doi: 10.1158/1078-0432.CCR-18-3169.
   PubMed Web of Science ®Google Scholar
• Zhu L, Li J, Gong Y, et al. Exosomal tRNA-derived small RNA as a promising biomarker for cancer diagnosis. Mol Cancer. 2019;18(1):74. doi: 10.1186/s12943-019-1000-8.
   PubMed Web of Science ®Google Scholar
• Li K, Lin Y, Zhou Y, et al. Salivary extracellular microRNAs for early detection and prognostication of esophageal cancer: a clinical study. Gastroenterology. 2023;165(4):932–945.e9. doi: 10.1053/j.gastro.2023.06.021.
   PubMed Web of Science ®Google Scholar
• Liu T, Du LT, Wang YS, et al. Development of a novel serum exosomal microRNA nomogram for the preoperative prediction of lymph node metastasis in esophageal squamous cell carcinoma. Front Oncol. 2020;10:573501. doi: 10.3389/fonc.2020.573501.
   PubMed Web of Science ®Google Scholar
• Fan L, Cao Q, Liu J, et al. Circular RNA profiling and its potential for esophageal squamous cell cancer diagnosis and prognosis. Mol Cancer. 2019;18(1):16. doi: 10.1186/s12943-018-0936-4.
   PubMed Web of Science ®Google Scholar
• Zhao A, Guo L, Xu J, et al. Identification and validation of circulating exosomes-based liquid biopsy for esophageal cancer. Cancer Med. 2019;8(7):3566–3574. doi: 10.1002/cam4.2224.
   PubMed Web of Science ®Google Scholar
• Liu S, Lin Z, Zheng Z, et al. Serum exosomal microRNA-766-3p expression is associated with poor prognosis of esophageal squamous cell carcinoma. Cancer Sci. 2020;111(10):3881–3892. doi: 10.1111/cas.14550.
   PubMed Web of Science ®Google Scholar
• Qiu ML, Li X, Lin JB, et al. Serum exosomal miR-182 upregulation predicts unfavorable prognosis of esophageal squamous cell carcinoma. Eur Rev Med Pharmacol Sci. 2020;24(10):5412–5418. doi: 10.26355/eurrev_202005_21325.
   PubMed Web of Science ®Google Scholar
• Liu Z, Huang Y, Han Z, et al. Exosome-mediated miR-25/miR-203 as a potential biomarker for esophageal squamous cell carcinoma: improving early diagnosis and revealing malignancy. Transl Cancer Res. 2021;10(12):5174–5182. doi: 10.21037/tcr-21-1123.
   PubMed Web of Science ®Google Scholar
• Liu S, Lin Z, Rao W, et al. Upregulated expression of serum exosomal hsa_circ_0026611 is associated with lymph node metastasis and poor prognosis of esophageal squamous cell carcinoma. J Cancer. 2021;12(3):918–926. doi: 10.7150/jca.50548.
   PubMed Web of Science ®Google Scholar
• Lu Q, Wang X, Zhu J, et al. Hypoxic tumor-derived exosomal Circ0048117 facilitates M2 macrophage polarization acting as miR-140 sponge in esophageal squamous cell carcinoma. Onco Targets Ther. 2020;13:11883–11897. doi: 10.2147/OTT.S284192.
   PubMed Web of Science ®Google Scholar
• Yan S, Du L, Jiang X, et al. Evaluation of serum exosomal lncRNAs as diagnostic and prognostic biomarkers for esophageal squamous cell carcinoma. Cancer Manag Res. 2020;12:9753–9763. doi: 10.2147/CMAR.S250971.
   PubMed Web of Science ®Google Scholar
• Xie K, Zheng C, Gu W, et al. A RASSF8-AS1 based exosomal lncRNAs panel used for diagnostic and prognostic biomarkers for esophageal squamous cell carcinoma. Thorac Cancer. 2022;13(23):3341–3352. doi: 10.1111/1759-7714.14690.
   PubMed Web of Science ®Google Scholar
• Du X, Zhang X, Dong J, et al. Irradiation-induced exosomal HMGB1 to confer radioresistance via the PI3K/AKT/FOXO3A signaling pathway in ESCC. J Transl Med. 2022;20(1):507. doi: 10.1186/s12967-022-03720-0.
   PubMed Web of Science ®Google Scholar
• Zhou X, Wen W, Zhu J, et al. A six-microRNA signature in plasma was identified as a potential biomarker in diagnosis of esophageal squamous cell carcinoma. Oncotarget. 2017;8(21):34468–34480. doi: 10.18632/oncotarget.16519.
   PubMedGoogle Scholar
• Kim S, Kim GH, Park SJ, et al. Exosomal microRNA analyses in esophageal squamous cell carcinoma cell lines. J Clin Med. 2022;11(15):4426. doi: 10.3390/jcm11154426.
   PubMed Web of Science ®Google Scholar
• Jiao Z, Yu A, Rong W, et al. Five-lncRNA signature in plasma exosomes serves as diagnostic biomarker for esophageal squamous cell carcinoma. Aging. 2020;12(14):15002–15010. doi: 10.18632/aging.103559.
   PubMedGoogle Scholar
• Sun Y, Qian Y, Chen C, et al. Extracellular vesicle IL-32 promotes the M2 macrophage polarization and metastasis of esophageal squamous cell carcinoma via FAK/STAT3 pathway. J Exp Clin Cancer Res. 2022;41(1):145. doi: 10.1186/s13046-022-02348-8.
   PubMed Web of Science ®Google Scholar
• Tang B, Zhang Q, Liu K, et al. Exosomal circRNA FNDC3B promotes the progression of esophageal squamous cell carcinoma by sponging miR-490-5p and regulating thioredoxin reductase 1 expression. Bioengineered. 2022;13(5):13829–13848. doi: 10.1080/21655979.2022.2084484.
   PubMed Web of Science ®Google Scholar
• Xu ML, Liu TC, Dong FX, et al. Exosomal lncRNA LINC01711 facilitates metastasis of esophageal squamous cell carcinoma via the miR-326/FSCN1 axis. Aging. 2021;13(15):19776–19788. doi: 10.18632/aging.203389.
   PubMedGoogle Scholar
• Zhang C, Luo Y, Cao J, et al. Exosomal lncRNA FAM225A accelerates esophageal squamous cell carcinoma progression and angiogenesis via sponging miR-206 to upregulate NETO2 and FOXP1 expression. Cancer Med. 2020;9(22):8600–8611. doi: 10.1002/cam4.3463.
   PubMed Web of Science ®Google Scholar
• Li W, Zhang L, Guo B, et al. Exosomal FMR1-AS1 facilitates maintaining cancer stem-like cell dynamic equilibrium via TLR7/NFκB/c-Myc signaling in female esophageal carcinoma. Mol Cancer. 2019;18(1):22. doi: 10.1186/s12943-019-0949-7.
   PubMedGoogle Scholar
• Li Z, Qin X, Bian W, et al. Exosomal lncRNA ZFAS1 regulates esophageal squamous cell carcinoma cell proliferation, invasion, migration and apoptosis via microRNA-124/STAT3 axis. J Exp Clin Cancer Res. 2019;38(1):477. doi: 10.1186/s13046-019-1473-8.
   PubMed Web of Science ®Google Scholar
• Shi Z, Jiang T, Cao B, et al. CAF-derived exosomes deliver LINC01410 to promote epithelial-mesenchymal transition of esophageal squamous cell carcinoma. Exp Cell Res. 2022;412(2):113033. doi: 10.1016/j.yexcr.2022.113033.
   PubMed Web of Science ®Google Scholar
• Ma J, Xiao Y, Tian B, et al. Genome-wide analyses of long non-coding RNA expression profiles and functional network analysis in esophageal squamous cell carcinoma. Sci Rep. 2019;9(1):9162. doi: 10.1038/s41598-019-45493-5.
   PubMedGoogle Scholar
• Zhao F, Li Z, Dong Z, et al. Exploring the potential of exosome-related LncRNA pairs as predictors for immune microenvironment, survival outcome, and microbiotain landscape in esophageal squamous cell carcinoma. Front Immunol. 2022;13:918154. doi: 10.3389/fimmu.2022.918154.
   PubMed Web of Science ®Google Scholar
• Li P, Liu X, Xing W, et al. Exosome-derived miR-200a promotes esophageal cancer cell proliferation and migration via the mediating Keap1 expression. Mol Cell Biochem. 2022;477(4):1295–1308. doi: 10.1007/s11010-022-04353-z.
   PubMed Web of Science ®Google Scholar
• Zhang Y, Chen C, Liu Z, et al. PABPC1-induced stabilization of IFI27 mRNA promotes angiogenesis and malignant progression in esophageal squamous cell carcinoma through exosomal miRNA-21-5p. J Exp Clin Cancer Res. 2022;41(1):111. doi: 10.1186/s13046-022-02339-9.
   PubMed Web of Science ®Google Scholar
• He Z, Li W, Zheng T, et al. Human umbilical cord mesenchymal stem cells-derived exosomes deliver microRNA-375 to downregulate ENAH and thus retard esophageal squamous cell carcinoma progression. J Exp Clin Cancer Res. 2020;39(1):140. doi: 10.1186/s13046-020-01631-w.
   PubMed Web of Science ®Google Scholar
• Jin Y, Meng Q, Zhang B, et al. Cancer-associated fibroblasts-derived exosomal miR-3656 promotes the development and progression of esophageal squamous cell carcinoma via the ACAP2/PI3K-AKT signaling pathway. Int J Biol Sci. 2021;17(14):3689–3701. doi: 10.7150/ijbs.62571.
   PubMed Web of Science ®Google Scholar
• Tan X, Ren S, Fu MZ, et al. microRNA-196b promotes esophageal squamous cell carcinogenesis and chemoradioresistance by inhibiting EPHA7, thereby restoring EPHA2 activity. Am J Cancer Res. 2021;11(7):3594–3610.
   PubMed Web of Science ®Google Scholar
• Chen F, Chu L, Li J, et al. Hypoxia induced changes in miRNAs and their target mRNAs in extracellular vesicles of esophageal squamous cancer cells. Thorac Cancer. 2020;11(3):570–580. doi: 10.1111/1759-7714.13295.
   PubMed Web of Science ®Google Scholar
• Zhao Q, Huang L, Qin G, et al. Cancer-associated fibroblasts induce monocytic myeloid-derived suppressor cell generation via IL-6/exosomal miR-21-activated STAT3 signaling to promote cisplatin resistance in esophageal squamous cell carcinoma. Cancer Lett. 2021;518:35–48. doi: 10.1016/j.canlet.2021.06.009.
   PubMed Web of Science ®Google Scholar
• Sun Y, Wang J, Ma Y, et al. Radiation induces NORAD expression to promote ESCC radiotherapy resistance via EEPD1/ATR/Chk1 signalling and by inhibiting pri-miR-199a1 processing and the exosomal transfer of miR-199a-5p. J Exp Clin Cancer Res. 2021;40(1):306. doi: 10.1186/s13046-021-02084-5.
   PubMed Web of Science ®Google Scholar
• Wang H, Qi Y, Lan Z, et al. Exosomal PD-L1 confers chemoresistance and promotes tumorigenic properties in esophageal cancer cells via upregulating STAT3/miR-21. Gene Ther. 2023;30(1-2):88–100. doi: 10.1038/s41434-022-00331-8.
   PubMed Web of Science ®Google Scholar
• Cui Y, Zhang S, Hu X, et al. Tumor-associated fibroblasts derived exosomes induce the proliferation and cisplatin resistance in esophageal squamous cell carcinoma cells through RIG-I/IFN-β signaling. Bioengineered. 2022;13(5):12462–12474. doi: 10.1080/21655979.2022.2076008.
   PubMed Web of Science ®Google Scholar
• Zhao G, Li H, Guo Q, et al. Exosomal sonic hedgehog derived from cancer-associated fibroblasts promotes proliferation and migration of esophageal squamous cell carcinoma. Cancer Med. 2020;9(7):2500–2513. doi: 10.1002/cam4.2873.
   PubMed Web of Science ®Google Scholar
• Li B, Song TN, Wang FR, et al. Tumor-derived exosomal HMGB1 promotes esophageal squamous cell carcinoma progression through inducing PD1+ TAM expansion. Oncogenesis. 2019;8(3):17. doi: 10.1038/s41389-019-0126-2.
   PubMedGoogle Scholar
• Ding Z, Yan Y, Guo YL, et al. Esophageal carcinoma cell-excreted exosomal uc.189 promotes lymphatic metastasis. Aging. 2021;13(10):13846–13858. doi: 10.18632/aging.202979.
   PubMedGoogle Scholar
• Zheng K, Ma J, Wang Y, et al. Sulforaphane inhibits autophagy and induces exosome-Mediated paracrine senescence via regulating mTOR/TFE3. Mol Nutr Food Res. 2020;64(14):e1901231. doi: 10.1002/mnfr.201901231.
   PubMed Web of Science ®Google Scholar
• Min H, Sun X, Yang X, et al. Exosomes derived from irradiated esophageal carcinoma-infiltrating T cells promote metastasis by inducing the epithelial-mesenchymal transition in esophageal cancer cells. Pathol Oncol Res. 2018;24(1):11–18. doi: 10.1007/s12253-016-0185-z.
   PubMed Web of Science ®Google Scholar
• Mao Y, Wang Y, Dong L, et al. Hypoxic exosomes facilitate angiogenesis and metastasis in esophageal squamous cell carcinoma through altering the phenotype and transcriptome of endothelial cells. J Exp Clin Cancer Res. 2019;38(1):389. doi: 10.1186/s13046-019-1384-8.
   PubMed Web of Science ®Google Scholar
• Tong Y, Yang L, Yu C, et al. Tumor-secreted exosomal lncRNA POU3F3 promotes cisplatin resistance in ESCC by inducing fibroblast differentiation into CAFs. Mol Ther Oncolytics. 2020;18:1–13. doi: 10.1016/j.omto.2020.05.014.
   PubMed Web of Science ®Google Scholar
• Ma J, Xiao Y, Tian B, et al. Long noncoding RNA lnc-ABCA12-3 promotes cell migration, invasion, and proliferation by regulating fibronectin 1 in esophageal squamous cell carcinoma. J Cell Biochem. 2020;121(2):1374–1387. doi: 10.1002/jcb.29373.
   PubMed Web of Science ®Google Scholar
• Zhu Q, Huang L, Yang Q, et al. Metabolomic analysis of exosomal-markers in esophageal squamous cell carcinoma. Nanoscale. 2021;13(39):16457–16464. doi: 10.1039/D1NR04015D.
   PubMed Web of Science ®Google Scholar
• Zhang Y, Lu W, Chen Y, et al. The miR-19b-3p-MAP2K3-STAT3 feedback loop regulates cell proliferation and invasion in esophageal squamous cell carcinoma. Mol Oncol. 2021;15(5):1566–1583. doi: 10.1002/1878-0261.12934.
   PubMed Web of Science ®Google Scholar
• Gao DC, Hou B, Zhou D, et al. Tumor-derived exosomal miR-103a-2-5p facilitates esophageal squamous cell carcinoma cell proliferation and migration. Eur Rev Med Pharmacol Sci. 2020;24(11):6097–6110. doi: 10.26355/eurrev_202006_21505.
   PubMed Web of Science ®Google Scholar
• Xiao Z, Feng X, Zhou Y, et al. Exosomal miR-10527-5p inhibits migration, invasion, lymphangiogenesis and lymphatic metastasis by affecting wnt/β-catenin signaling via Rab10 in esophageal squamous cell carcinoma. Int J Nanomedicine. 2023;18:95–114. doi: 10.2147/IJN.S391173.
   PubMed Web of Science ®Google Scholar
• Yang L, Salai A, Sun X, et al. Proteomic profiling of plasma exosomes reveals CD82 involvement in the development of esophageal squamous cell carcinoma. J Proteomics. 2022;265:104662. doi: 10.1016/j.jprot.2022.104662.
   PubMed Web of Science ®Google Scholar
• Yang L, Zheng S, Liu Q, et al. Plasma‑derived exosomal pyruvate kinase isoenzyme type M2 accelerates the proliferation and motility of oesophageal squamous cell carcinoma cells. Oncol Rep. 2021;46(4):216. doi: 10.3892/or.2021.8167.
   PubMed Web of Science ®Google Scholar
• Matsumoto Y, Kano M, Akutsu Y, et al. Quantification of plasma exosome is a potential prognostic marker for esophageal squamous cell carcinoma. Oncol Rep. 2016;36(5):2535–2543. doi: 10.3892/or.2016.5066.
   PubMed Web of Science ®Google Scholar
• Ma J, Luo Y, Liu Y, et al. Exosome-mediated lnc-ABCA12-3 promotes proliferation and glycolysis but inhibits apoptosis by regulating the toll-like receptor 4/nuclear factor kappa-B signaling pathway in esophageal squamous cell carcinoma. Korean J Physiol Pharmacol. 1993;27(1):61–73. doi: 10.4196/kjpp.2023.27.1.61.
   Google Scholar
• Liu T, Li P, Li J, et al. Exosomal and intracellular miR-320b promotes lymphatic metastasis in esophageal squamous cell carcinoma. Mol Ther Oncolytics. 2021;23:163–180. doi: 10.1016/j.omto.2021.09.003.
   PubMed Web of Science ®Google Scholar
• Luo A, Zhou X, Shi X, et al. Exosome-derived miR-339-5p mediates radiosensitivity by targeting Cdc25A in locally advanced esophageal squamous cell carcinoma. Oncogene. 2019;38(25):4990–5006. doi: 10.1038/s41388-019-0771-0.
   PubMed Web of Science ®Google Scholar
• Yan D, Cui D, Zhu Y, et al. M6PR- and EphB4-Rich exosomes secreted by serglycin-overexpressing esophageal cancer cells promote cancer progression. Int J Biol Sci. 2023;19(2):625–640. doi: 10.7150/ijbs.79875.
   PubMed Web of Science ®Google Scholar
• Qiao Y, Li J, Shi C, et al. Prognostic value of circulating tumor cells in the peripheral blood of patients with esophageal squamous cell carcinoma. Onco Targets Ther. 2017;10:1363–1373. doi: 10.2147/OTT.S129004.
   PubMed Web of Science ®Google Scholar
• Lin D, Shen L, Luo M, et al. Circulating tumor cells: biology and clinical significance. Signal Transduct Target Ther. 2021;6(1):404. doi: 10.1038/s41392-021-00817-8.
   PubMed Web of Science ®Google Scholar
• Tsavlis D, Katopodi T, Anestakis D, et al. Molecular and immune phenotypic modifications during metastatic dissemination in lung carcinogenesis. Cancers. 2022;14(15):3626. doi: 10.3390/cancers14153626.
   PubMed Web of Science ®Google Scholar
• Ronvaux L, Riva M, Coosemans A, et al. Liquid biopsy in glioblastoma. Cancers. 2022;14(14):3394. doi: 10.3390/cancers14143394.
   PubMed Web of Science ®Google Scholar
• Li H, Song P, Zou B, et al. Circulating tumor cell analyses in patients with esophageal squamous cell carcinoma using epithelial Marker-Dependent and -Independent approaches. Medicine. 2015;94(38):e1565. doi: 10.1097/MD.0000000000001565.
   PubMed Web of Science ®Google Scholar
• Boya M, Ozkaya-Ahmadov T, Swain BE, et al. High throughput, label-free isolation of circulating tumor cell clusters in meshed microwells. Nat Commun. 2022;13(1):3385. doi: 10.1038/s41467-022-31009-9.
   PubMed Web of Science ®Google Scholar
• Jiang S, Mao C, Jiang B, et al. High expression of BCAR1 by circulating tumor cells and tumor tissues is predictive of a poor prognosis of early-stage lung adenocarcinoma potentially due to regulation of epithelial-mesenchymal transition. Technol Cancer Res Treat. 2020;19:1533033820983086. doi: 10.1177/1533033820983086.
   Web of Science ®Google Scholar
• Montalbán-Hernández K, Cantero-Cid R, Casalvilla-Dueñas JC, et al. Colorectal cancer stem cells fuse with monocytes to form tumour hybrid cells with the ability to migrate and evade the immune system. Cancers. 2022;14(14):3445. doi: 10.3390/cancers14143445.
   PubMed Web of Science ®Google Scholar
• Gogoi P, Sepehri S, Zhou Y, et al. Development of an automated and sensitive microfluidic device for capturing and characterizing circulating tumor cells (CTCs) from clinical blood samples. PLOS One. 2016;11(1):e0147400. doi: 10.1371/journal.pone.0147400.
   PubMed Web of Science ®Google Scholar
• Ujiie D, Matsumoto T, Endo E, et al. Circulating tumor cells after neoadjuvant chemotherapy are related with recurrence in esophageal squamous cell carcinoma. Esophagus. 2021;18(3):566–573. doi: 10.1007/s10388-021-00829-x.
   PubMed Web of Science ®Google Scholar
• Li W, Liu JB, Hou LK, et al. Liquid biopsy in lung cancer: significance in diagnostics, prediction, and treatment monitoring. Mol Cancer. 2022;21(1):25. doi: 10.1186/s12943-022-01505-z.
   PubMed Web of Science ®Google Scholar
• Chen W, Li Y, Yuan D, et al. Practical value of identifying circulating tumor cells to evaluate esophageal squamous cell carcinoma staging and treatment efficacy: circulating tumor cells in ESCC. Thorac Cancer. 2018;9(8):956–966. doi: 10.1111/1759-7714.12771.
   PubMed Web of Science ®Google Scholar
• Han D, Chen K, Che J, et al. Detection of epithelial-mesenchymal transition status of circulating tumor cells in patients with esophageal squamous carcinoma. Biomed Res Int. 2018;2018:7610154. doi: 10.1155/2018/7610154.
   PubMed Web of Science ®Google Scholar
• Lee HJ, Kim GH, Park SJ, et al. Clinical significance of TWIST-Positive circulating tumor cells in patients with esophageal squamous cell carcinoma. Gut Liver. 2021;15(4):553–561. doi: 10.5009/gnl20194.
   PubMed Web of Science ®Google Scholar
• Choi MK, Kim GH, I H, et al. Circulating tumor cells detected using fluid-assisted separation technique in esophageal squamous cell carcinoma. J Gastroenterol Hepatol. 2019;34(3):552–560. doi: 10.1111/jgh.14543.
   PubMed Web of Science ®Google Scholar
• Zhao Y, Zhao S, Chen Y, et al. Isolation of circulating tumor cells in patients undergoing surgery for esophageal cancer and a specific confirmation method. Oncol Lett. 2019;17(4):3817–3825. doi: 10.3892/ol.2019.10017.
   PubMed Web of Science ®Google Scholar
• Zhao Y, Han L, Zhang W, et al. Preoperative chemotherapy compared with postoperative adjuvant chemotherapy for squamous cell carcinoma of the thoracic oesophagus with the detection of circulating tumour cells randomized controlled trial. Int J Surg. 2020;73:1–8. doi: 10.1016/j.ijsu.2019.11.005.
   PubMed Web of Science ®Google Scholar
• Okumura T, Yamaguchi T, Watanabe T, et al. Flow cytometric detection of circulating tumor cells using a candidate stem cell marker, p75 neurotrophin receptor (p75NTR). Methods Mol Biol. 2017;1634:211–217. doi: 10.1007/978-1-4939-7144-2_18.
   PubMedGoogle Scholar
• Yamaguchi T, Okumura T, Hirano K, et al. Detection of circulating tumor cells by p75NTR expression in patients with esophageal cancer. World J Surg Oncol. 2016;14(1):40. doi: 10.1186/s12957-016-0793-9.
   PubMedGoogle Scholar
• Yin XD, Yuan X, Xue JJ, et al. Clinical significance of carcinoembryonic antigen-, cytokeratin 19-, or survivin-positive circulating tumor cells in the peripheral blood of esophageal squamous cell carcinoma patients treated with radiotherapy: circulating tumor cells in ESCC. Dis Esophagus. 2012;25(8):750–756. doi: 10.1111/j.1442-2050.2012.01326.x.
   PubMed Web of Science ®Google Scholar
• Zhang Y, Li J, Wang L, et al. Clinical significance of detecting circulating tumor cells in patients with esophageal squamous cell carcinoma by EpCAM‑independent enrichment and immunostaining‑fluorescence in situ hybridization. Mol Med Rep. 2019;20(2):1551–1560. doi: 10.3892/mmr.2019.10420.
   PubMed Web of Science ®Google Scholar
• Li SP, Guan Q L, Zhao D, et al. Detection of circulating tumor cells by fluorescent immunohistochemistry in patients with esophageal squamous cell carcinoma: potential clinical applications. Med Sci Monit. 2016;22:1654–1662. doi: 10.12659/MSM.898335.
   PubMed Web of Science ®Google Scholar
• Han L, Li YJ, Zhang WD, et al. Clinical significance of tumor cells in the peripheral blood of patients with esophageal squamous cell carcinoma. Medicine. 2019;98(6):e13921. doi: 10.1097/MD.0000000000013921.
   PubMed Web of Science ®Google Scholar
• Ko JMY, Ng HY, Lam KO, et al. Liquid biopsy serial monitoring of treatment responses and relapse in advanced esophageal squamous cell carcinoma. Cancers. 2020;12(6):1352. doi: 10.3390/cancers12061352.
   PubMed Web of Science ®Google Scholar
• Yuan Z, Wang X, Geng X, et al. Multi-region sequencing reveals genetic correlation between esophageal squamous cell carcinoma and matched cell-free DNA. Cancer Genet. 2021;258–259:93–100. doi: 10.1016/j.cancergen.2021.08.005.
   PubMed Web of Science ®Google Scholar
• Pantel K, Alix-Panabières C. Liquid biopsy and minimal residual disease – latest advances and implications for cure. Nat Rev Clin Oncol. 2019;16(7):409–424. doi: 10.1038/s41571-019-0187-3.
   PubMed Web of Science ®Google Scholar
• Boldrin E, Curtarello M, Fassan M, et al. Allelic imbalance analysis in liquid biopsy to monitor locally advanced esophageal cancer patients during treatment. Front Oncol. 2020;10:1320. doi: 10.3389/fonc.2020.01320.
   PubMed Web of Science ®Google Scholar
• Barbany G, Arthur C, Liedén A, et al. Cell-free tumour DNA testing for early detection of cancer – a potential future tool. J Intern Med. 2019;286(2):118–136. doi: 10.1111/joim.12897.
   PubMed Web of Science ®Google Scholar
• Jie X, Du M, Zhang M, et al. Mutation analysis of circulating tumor DNA and paired ascites and tumor tissues in ovarian cancer. Exp Ther Med. 2022;24(3):542. doi: 10.3892/etm.2022.11479.
   PubMed Web of Science ®Google Scholar
• Heitzer E, Haque IS, Roberts CES, et al. Current and future perspectives of liquid biopsies in genomics-driven oncology. Nat Rev Genet. 2019;20(2):71–88. doi: 10.1038/s41576-018-0071-5.
   PubMed Web of Science ®Google Scholar
• Abbosh C, Birkbak NJ, Swanton C. Early stage NSCLC—challenges to implementing ctDNA-based screening and MRD detection. Nat Rev Clin Oncol. 2018;15(9):577–586. doi: 10.1038/s41571-018-0058-3.
   PubMed Web of Science ®Google Scholar
• Diehl F, Li M, Dressman D, et al. Detection and quantification of mutations in the plasma of patients with colorectal tumors. Proc Natl Acad Sci USA. 2005;102(45):16368–16373. doi: 10.1073/pnas.0507904102.
   PubMed Web of Science ®Google Scholar
• Bettegowda C, Sausen M, Leary RJ, et al. Detection of circulating tumor DNA in early- and late-stage human malignancies. Sci Transl Med. 2014;6(224):224ra24. doi: 10.1126/scitranslmed.3007094.
   PubMed Web of Science ®Google Scholar
• Bian Y, Gao Y, Lu C, et al. Genome-wide methylation profiling identified methylated KCNA3 and OTOP2 as promising diagnostic markers for esophageal squamous cell carcinoma. Chin Med J. 2023. doi: 10.1097/CM9.0000000000002832.
   Google Scholar
• Hsieh CC, Hsu HS, Chang SC, et al. Circulating cell-free DNA levels could predict oncological outcomes of patients undergoing esophagectomy for esophageal squamous cell carcinoma. Int J Mol Sci. 2016;17(12):2131. doi: 10.3390/ijms17122131.
   PubMed Web of Science ®Google Scholar
• Tomochika S, Iizuka N, Watanabe Y, et al. Increased serum cell-free DNA levels in relation to inflammation are predictive of distant metastasis of esophageal squamous cell carcinoma. Exp Ther Med. 2010;1(1):89–92. doi: 10.3892/etm_00000016.
   PubMed Web of Science ®Google Scholar
• Wang X, Yu N, Cheng G, et al. Prognostic value of circulating tumour DNA during post-radiotherapy surveillance in locally advanced esophageal squamous cell carcinoma. Clin Transl Med. 2022;12(11):e1116. doi: 10.1002/ctm2.1116.
   PubMed Web of Science ®Google Scholar
• Nasrollahzadeh D, Roshandel G, Delhomme TM, et al. TP53 targeted deep sequencing of cell-free DNA in esophageal squamous cell carcinoma using low-quality serum: concordance with tumor mutation. Int J Mol Sci. 2021;22(11):5627. doi: 10.3390/ijms22115627.
   PubMed Web of Science ®Google Scholar
• Hagi T, Kurokawa Y, Takahashi T, et al. Molecular barcode sequencing for highly sensitive detection of circulating tumor DNA in patients with esophageal squamous cell carcinoma. Oncology. 2020;98(4):222–229. doi: 10.1159/000504808.
   PubMed Web of Science ®Google Scholar
• Liu T, Yao Q, Jin H. Plasma circulating tumor DNA sequencing predicts minimal residual disease in resectable esophageal squamous cell carcinoma. Front Oncol. 2021;11:616209. doi: 10.3389/fonc.2021.616209.
   PubMed Web of Science ®Google Scholar
• Zhao Q, Miao C, Lu Q, et al. Clinical significance of monitoring circulating free DNA and plasma heat shock protein 90alpha in patients with esophageal squamous cell carcinoma. Cancer Manag Res. 2021;13:2223–2234. doi: 10.2147/CMAR.S295927.
   PubMed Web of Science ®Google Scholar
• Meng P, Wei J, Geng Y, et al. Targeted sequencing of circulating cell-free DNA in stage II-III resectable oesophageal squamous cell carcinoma patients. BMC Cancer. 2019;19(1):818. doi: 10.1186/s12885-019-6025-2.
   PubMed Web of Science ®Google Scholar
• Yang D, Xu F, Li Y, et al. Assessment of durable chemoimmunotherapy response via circulating tumor DNA in advanced esophageal squamous cell carcinoma. Thorac Cancer. 2022;13(19):2786–2791. doi: 10.1111/1759-7714.14610.
   PubMed Web of Science ®Google Scholar
• Fujisawa R, Iwaya T, Endo F, et al. Early dynamics of circulating tumor DNA predict chemotherapy responses for patients with esophageal cancer. Carcinogenesis. 2021;42(10):1239–1249. doi: 10.1093/carcin/bgab088.
   PubMed Web of Science ®Google Scholar
• Wang Q, Liu H, Liu Z, et al. Circ-SLC7A5, a potential prognostic circulating biomarker for detection of ESCC. Cancer Genet. 2020;240:33–39. doi: 10.1016/j.cancergen.2019.11.001.
   PubMed Web of Science ®Google Scholar
• Huang Z, Zhang L, Zhu D, et al. A novel serum microRNA signature to screen esophageal squamous cell carcinoma. Cancer Med. 2017;6(1):109–119. doi: 10.1002/cam4.973.
   PubMed Web of Science ®Google Scholar
• Miyoshi J, Zhu Z, Luo A, et al. A microRNA-based liquid biopsy signature for the early detection of esophageal squamous cell carcinoma: a retrospective, prospective and multicenter study. Mol Cancer. 2022;21(1):44. doi: 10.1186/s12943-022-01507-x.
   PubMed Web of Science ®Google Scholar
• Sun G, Ye H, Wang X, et al. Autoantibodies against tumor-associated antigens combined with microRNAs in detecting esophageal squamous cell carcinoma. Cancer Med. 2020;9(3):1173–1182. doi: 10.1002/cam4.2792.
   PubMed Web of Science ®Google Scholar
• Ibuki Y, Nishiyama Y, Tsutani Y, et al. Circulating microRNA/isomiRs as novel biomarkers of esophageal squamous cell carcinoma. PLOS One. 2020;15(4):e0231116. doi: 10.1371/journal.pone.0231116.
   PubMed Web of Science ®Google Scholar
• Khazaei S, Nouraee N, Moradi A, et al. A novel signaling role for miR-451 in esophageal tumor microenvironment and its contribution to tumor progression. Clin Transl Oncol. 2017;19(5):633–640. doi: 10.1007/s12094-016-1575-0.
   PubMed Web of Science ®Google Scholar
• Takeshita N, Hoshino I, Mori M, et al. Serum microRNA expression profile: miR-1246 as a novel diagnostic and prognostic biomarker for oesophageal squamous cell carcinoma. Br J Cancer. 2013;108(3):644–652. doi: 10.1038/bjc.2013.8.
   PubMed Web of Science ®Google Scholar
• Hoshino I, Ishige F, Iwatate Y, et al. Cell-free microRNA-1246 in different body fluids as a diagnostic biomarker for esophageal squamous cell carcinoma. PLOS One. 2021;16(3):e0248016. doi: 10.1371/journal.pone.0248016.
   PubMed Web of Science ®Google Scholar